Inventor · disambiguated record
Eli C. Lewis
Also filed as: LEWIS ELI · LEWIS ELI C · LEWIS ELI CHAIM
7 granted patents·20 pending applications·16 citations·filing 2006–2024
79Inventor score
Files withUNIV COLORADO REGENTS6B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV3DINARELLO CHARLES A3LEWIS ELI C3BEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY2
Top patents by PatentIndex Score
27 records- 0184US9457070B2Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host diseaseDINARELLO CHARLES A·Filed 2011·Granted Oct 4, 2016·7 cites·5 claims
- 0279US9884096B2Compositions and methods related to graft versus host disease and treatments thereofTHE REGENTS OF THE UNIV OF COLORADO A BODY·Filed 2014·Granted Feb 6, 2018·4 cites·10 claims
- 0376US8715649B2Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activityDINARELLO CHARLES A·Filed 2009·Granted May 6, 2014·3 cites·10 claims
- 0471US9522179B2Compositions and methods for modulating cardiac conditionsDINARELLO CHARLES A·Filed 2011·Granted Dec 20, 2016·2 cites·20 claims
- 0570US2025195630A1Compositions, methods and uses of alpha 1-antitrypsin for treatment of graft versus host diseaseUNIV COLORADO REGENTS·Filed 2024·Application pending·0 cites
- 0665US2009220518A1Methods and compositions for treatment of graft rejection and promotion of graft survivalUNIV COLORADO·Filed 2008·Application pending·0 cites
- 0765US2020206328A1Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host diseaseUNIV COLORADO REGENTS·Filed 2020·Application pending·0 cites
- 0862US2018133294A1Compositions and methods related to graft versus host disease and treatments thereofTHE UNIV OF COLORADO A BODY CORPORATE·Filed 2017·Application pending·0 cites
- 0960US10086070B2Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejectionBEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY·Filed 2017·Granted Oct 2, 2018·0 cites·12 claims
- 1060US2009118162A1Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survivalUNIV COLORADO·Filed 2006·Application pending·0 cites
- 1158US2014127201A1Compositions and methods related to graft versus host disease and treatments thereofUNIV COLORADO REGENTS·Filed 2013·Application pending·0 cites
- 1256US2012045417A1Methods and compositions for islet cell preservationLEWIS ELI C·Filed 2011·Application pending·0 cites
- 1356US2012045460A1Methods and compositions for treatment of graft rejection and promotion of graft survivalLEWIS ELI C·Filed 2011·Application pending·0 cites
- 1456US2020222516A1Compositions and Methods for Modulating Cardiac ConditionsUNIV COLORADO REGENTS·Filed 2019·Application pending·0 cites
- 1555US2025368466A1Handheld tape dispenser and methods of use thereofLEWIS ELI·Filed 2024·Application pending·0 cites
- 1655US2015010581A1Combined therapy of alpha-1-antitrypsin and temporal t-cell depletion for preventing graft rejectionUNIV BEN GURION·Filed 2013·Application pending·0 cites
- 1751US2011237496A1Antinecrotic activity of alpha 1-antitrypsinNATHAN ILANA·Filed 2009·Application pending·0 cites
- 1850US2021000931A1Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activityUNIV COLORADO REGENTS·Filed 2020·Application pending·0 cites
- 1948US9895420B2IL-1beta propeptide and IL-1Ra chimera and methods of using the sameB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2014·Granted Feb 20, 2018·0 cites·18 claims
- 2048US2017209555A1Compositions and Methods for Modulating Cardiac ConditionsUNIV COLORADO REGENTS·Filed 2016·Application pending·0 cites
- 2146US2019307866A1Antinecrotic activity of alpha 1-antitrypsinBEN GURION UNIV OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY·Filed 2019·Application pending·0 cites
- 2245US2017000864A1Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host diseaseTHE REGENTS OF THE UNIV OF COLORADO A BODY COPORATE·Filed 2016·Application pending·0 cites
- 2344US2023068487A1Alpha-1-antitrypsin mutants, compositions comprising same, and use thereofB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2021·Application pending·0 cites
- 2441US11492390B2Mutant alpha-1-antitrypsin compositions and use thereofB G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV·Filed 2018·Granted Nov 8, 2022·0 cites·12 claims
- 2540US2021052777A1Methods and compositions for treating and preventing diabetesTECHNION RES & DEV FOUNDATION·Filed 2019·Application pending·0 cites
- 2636US2012225813A1Compositions, methods and uses for treatment of type 1 diabetesLEWIS ELI C·Filed 2011·Application pending·0 cites
- 2733US2011112017A1Compositions, methods and uses for treating diabetesSHAPIRO LEE·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →